Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition

Rhythm Pharmaceuticals said on Tuesday its experimental weekly injectable drug helped reduce body weight in patients with a rare ​form of obesity caused by damage to the brain, ‌according to prelimina...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。